The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).
If you sit with Kevin Fitzgerald long enough, it’s only a matter of time before the local legend is greeted by fans who ...
The quick answer is, it's complicated. Number one, quality. Number three, delay of the product. because it's no longer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback